Clinical trials
Observational alpha-Thalassemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cyprus Institute of Neurology and Genetics | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| University of California, San Francisco | 1 |
| xCures | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| alpha-Thalassemia | 4 |
| Anemia, Sickle Cell | 2 |
| beta-Thalassemia | 2 |
| Alzheimer Disease | 1 |
| Amyloidosis | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Cystic Fibrosis | 1 |
| Ehlers-Danlos Syndrome | 1 |
| Gangliosidosis, GM1 | 1 |
| Gaucher Disease | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.